Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018

US$ 3,500.00

... Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

October 2018 56 pages

Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2018

US$ 3,500.00

... Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

October 2018 68 pages

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2018

US$ 3,500.00

... Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

October 2018 88 pages

P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) - Pipeline Review, H2 2018

US$ 3,500.00

... also reviews key players involved in P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) targeted therapeutics development with respective ...

October 2018 48 pages

Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) development ...

October 2018 171 pages

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) development landscape Develop and design ...

October 2018 107 pages

Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Pipeline Review, H2 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) development landscape Develop and design in-licensing ...

October 2018 118 pages

Pharmaceutical Cartridges Market Size, Share & Trends Analysis Report By Material Type (Glass, Plastic), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2018 - 2026

US$ 5,950.00

... pharmaceutical cartridges market size is expected to reach USD 1.83 billion by 2026, according to a new report by Grand View Research, Inc. The market ... share due to increased cases of diabetes and other chronic diseases among all age groups Some of the key companies in the pharmaceutical cartridges market ...

October 2018 79 pages

Vaginitis Therapeutics Market Size, Share, & Trends Analysis Report By Product (Anti-fungal, Hormone, Anti-bacterial), By Type (OTC, Prescription), By Region (APAC, MEA, North America), And Segment Forecasts, 2018 - 2025

US$ 5,950.00

The global vaginitis therapeutics market size is expected to reach USD 4.21 billion ... adoption of products Prescription type held the largest market share in 2017, in terms of revenue. The ... large target population base. Key players in the vaginitis therapeutics market are Pfizer, Inc.; Merck & Co.; Novartis AG; ...

October 2018 75 pages

Global Vitamin K1 Market Outlook 2018-2023

US$ 3,000.00

... Global Market for vitamin K1 to 2023 offers detailed coverage of vitamin K1 industry and presents main market trends. The market research gives historical and forecast market ... the vitamin K1. Report contents include Analysis of the vitamin K1 market including revenues, future growth, market outlook Historical ...

October 2018 143 pages

Pharmacy Retail Market in India (2018-2023) with data on Segments (Generic Drugs, OTC Medicines, Patented Drugs) Healthcare expenditure (Pharmacies, Private hospitals, Government hospitals, Diagnostic Laboratories, Patient transportation)

US$ 950.00

The report is sent in 0-2 business days after order is placed. India pharmacy retail market Pharmacy retail refers to the sale of pharmaceutical products, which include over-the- ...

October 2018 44 pages

Global Cardio-Protective Drug Market Research and Forecast, 2018-2023

US$ 3,600.00

... government policies impacting the global cardio-protective drug market. Insights about market determinants which are stimulating the Global Cardioprotective drug market. Detailed and extensive market segments with regional ...

October 2018 -

Transdermal Drug Delivery System Market - Forecasts from 2018 to 2023

US$ 3,950.00

... transdermal drug delivery system market is estimated to register a CAGR of 8.91% over the forecast period of 2017-2023. Transdermal drug delivery involves delivering the drug the medications in systemic ... understanding of the global transdermal drug delivery system market. Major industry players profiled ...

October 2018 100 pages

Mobile Engagement Market by User Type (SME, LSE), Solution (SMS & MMS, Push Notification, In-App Messaging, E-mail, App/Web Content), Vertical (Financial Services, Retail, Travel & Hospitality, Telecom & IT), and Region - Global Forecast to 2023

US$ 3,390.00

... the Report: This report includes statistics pertaining to the mobile engagement market by user type, solution, vertical, and geography. The strategic ... provided for the mobile engagement market. The major drivers, restraints, challenges, and opportunities for the mobile engagement market have been described ...

October 2018 143 pages

Global Duchenne Muscular Dystrophy Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... the Report: This report focuses on the Duchenne Muscular Dystrophy Drugs in global market, especially in North America, Europe and ... Chapters to deeply display the global Duchenne Muscular Dystrophy Drugs market. Chapter 1, to describe Duchenne Muscular Dystrophy Drugs Introduction, product scope, market ...

October 2018 150 pages

Global Dyslipidemia Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Dyslipidemia Drugs, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

October 2018 149 pages

Global Hepatic Encephalopathy (HE) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... primary growth drivers for the global hepatic encephalopathy (HE) therapeutics market till 2023. Such programs increase ... Chapters to deeply display the global Hepatic Encephalopathy (HE) Therapeutics market. Chapter 1, to describe Hepatic Encephalopathy (HE) Therapeutics Introduction, product scope, market ...

October 2018 118 pages

Global Antidepressant Drugs Market Forecast up to 2018 – 2024

US$ 2,750.00

... a challenge faced globally. Market Analysis: The “global antidepressant drugs market” is estimated to witness a CAGR of 2.2% during the forecast period 2018–2024. The global antidepressant drugs market is analyzed based on drug class and regions ...

October 2018 104 pages

Mycosis Fungoides (MF) - Market Insights, Epidemiology and Market Forecast-2028

US$ 6,250.00

... Fungoides Pipeline Analysis Mycosis Fungoides Market Size and Trends Mycosis Fungoides Market Opportunities Impact of upcoming Therapies in Mycosis Fungoides Mycosis Fungoides Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

October 2018 136 pages

Allergic Conjunctivitis (AC) - Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

... Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Allergic Conjunctivitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake ...

October 2018 118 pages

Cinryze - Drug Insights, 2018

US$ 1,000.00

... the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also ...

October 2018 34 pages

Market for Active Pharmaceutical Ingredients in China - Forecast and Analysis 2018

US$ 850.00

... . Impacts on the Asia Pacific active pharmaceutical ingredients market are also analyzed. With section E, we begin our analysis of the market for active pharmaceutical ingredients in China. This section analyzes the ...

October 2018 160 pages

Market for Active Pharmaceutical Ingredients in India - Forecast and Analysis 2018

US$ 850.00

... further contribute to the growth of the active pharmaceutical ingredient market in India. The market for APIs in India is expected to cross revenues of ... active pharmaceutical ingredients market are also analyzed. With section E, we begin our analysis of the market for active pharmaceutical ingredients in India ...

October 2018 165 pages

Hepatocellular Carcinoma - Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

... Forecast G8 Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hepatocellular Carcinoma Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

October 2018 201 pages

Primary Hyperoxaluria (PH) - Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Primary Hyperoxaluria (PH) Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

October 2018 117 pages

Tuberous Sclerosis Complex (TSC) - Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Tuberous Sclerosis Complex (TSC) Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

October 2018 118 pages

Advances in Biopharmaceutical Technology in China, 2nd Ed

US$ 2,950.00

... Microbiology and Biotechnology and BioPlan Associates Advances in Biopharmaceutical Technology, 2nd ed - A new opportunity ... biopharmaceutical industry, and the state of technology in China. A peer-reviewed, ready reference for all aspects of biopharmaceuticals in China, including an understanding of the China ...

October 2018 1154 pages

Calciphylaxis - Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

This report can be delivered to the clients within 24 hours DelveInsight’s ‘Calciphylaxis - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the d...

October 2018 120 pages

Down Syndrome - Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

This report can be delivered to the clients within 24 hours DelveInsight’s ‘Down Syndrome - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the d...

October 2018 120 pages

Obstructive Sleep Apnea (OSA)- Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

This report can be delivered to the clients within 24 hours DelveInsight’s ‘Obstructive Sleep Apnea (OSA)- Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth underst...

October 2018 120 pages

Post-Cardiac Arrest Syndrome (PCAS) - Market Insights, Epidemiology and Market Forecast-2027

US$ 6,250.00

This report can be delivered to the clients within 24 hours DelveInsight’s ‘Post-Cardiac Arrest Syndrome (PCAS) - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth...

October 2018 120 pages

Sezary Syndrome (SS) - Market Insights, Epidemiology and Market Forecast-2028

US$ 6,250.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Sezary Syndrome (SS) - Market Insights, Epidemiology and Market Forecast-2028’ report delivers an in-depth understanding o...

October 2018 141 pages

Human Vaccines: Market Research Report

US$ 5,600.00

... report analyzes the worldwide markets for Human Vaccines in US$ Million by the following Product Segments: Pediatric Vaccines, and Adult Vaccines. The report provides separate ... Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

September 2018 380 pages

Pharmaceutical Packaging Machinery - Global Market Outlook (2017-2026)

US$ 4,150.00

... for packaging of pharmaceutical products and thus paves a way for innovations in drug delivery systems. By package type, blister packaging machinery has ... GmbH, Svanguard Pharmaceutical Machinery, Inc., A.M.R.P. HANDELS AG (CAM), Trustar Pharma & Packing Equipment Co. Ltd., Accutek Packaging Equipment Companies, ...

September 2018 170 pages

Global Cholera Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Cholera Vaccines, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

September 2018 123 pages

Global Ulcerative Colitis Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Ulcerative Colitis Treatment market. Chapter 1, to describe Ulcerative Colitis Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Ulcerative Colitis Treatment, with ...

September 2018 121 pages

Global Intravenous (IV) Iron Drugs Market: Size, Trends and Forecasts (2018-2022)

US$ 1,600.00

... of intravenous (IV) iron drugs market produce intravenous iron drugs for different indications, with different iron content and in different doses. However, the competition in the global intravenous (IV) iron drugs market is dominated by few intravenous iron drugs ...

September 2018 102 pages

Melanocortin Receptor 4 (MC4R) - Pipeline Review, H2 2018

US$ 3,500.00

... Melanocortin Receptor 4 (MC4R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 66 pages

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) development landscape Develop and ...

September 2018 29 pages

Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Pipeline Review, H2 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) development landscape ...

September 2018 51 pages

Human Parainfluenza Virus 3 Infections - Pipeline Review, H2 2018

US$ 2,000.00

... . The Human Parainfluenza Virus 3 Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Human Parainfluenza Virus 3 Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2018 33 pages

Global Parkinson's Disease Drugs Market 2018-2024

US$ 3,250.00

... functionality. This is demanding more innovative and novel drugs for the treatment. Market Analysis: The “Global Parkinson’s Disease Drugs Market” is estimated to witness a CAGR of 7.2% during the forecast ...

September 2018 110 pages

Global Animal Antibacterial and Antibiotics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... the Report: This report focuses on the Animal Antibacterial and Antibiotics in global market, especially in North America, Europe and ... to deeply display the global Animal Antibacterial and Antibiotics market. Chapter 1, to describe Animal Antibacterial and Antibiotics Introduction, product scope, market ...

September 2018 138 pages

Global Antipsychotic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Antipsychotic Drugs, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

September 2018 118 pages

Global Recombinant Therapeutic Antibodies and Proteins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... on manufacturers, regions, type and application. The global recombinant therapeutic antibodies and proteins market size was valued at US$ ... to deeply display the global Recombinant Therapeutic Antibodies and Proteins market. Chapter 1, to describe Recombinant Therapeutic Antibodies and Proteins Introduction, ...

September 2018 119 pages

Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Pipeline Review, H2 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) development landscape Develop and design ...

September 2018 50 pages

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2018

US$ 3,500.00

... Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 57 pages

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2018

US$ 3,500.00

... Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 28 pages

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2018

US$ 3,500.00

... Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 61 pages

Ebola virus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2018

US$ 2,000.00

... . The Ebola virus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ebola virus Infections (Ebola Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

September 2018 276 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1